Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Feb 27
Love0

Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that imposes a substantial burden through persistent itch, sleep disturbance, and impaired quality of life. Despite major advances in systemic…
Read More
Feb 26
Love0

Regrowth of Eyebrows in a Previous Steroid Non-Responder With Alopecia Universalis After Ritlecitinib Treatment

By Chuck Lin No Comments
Dear Editor,This report highlights that intralesional corticosteroids may serve as adjunctive therapy in alopecia areata patients who were initially steroid non-responders after a period of treatment with Janus kinase inhibitors…
Read More
Feb 26
Love0

From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy

By Chuck Lin No Comments
INTRODUCTIONAlopecia areata (AA) is an autoimmune condition which affects roughly 2% of the population globally and is characterized by non-scarring hair loss.1 AA presents as patchy hair loss on the…
Read More
Feb 26
Love0

Updates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review

By Chuck Lin No Comments
INTRODUCTIONMale androgenetic alopecia (AGA) and female pattern hair loss (FPHL) are common nonscarring hair loss disorders characterized by progressive scalp thinning, affecting up to 50% of men and women.1 In…
Read More
Feb 26
Love0

Pseudo-Psoriatic Nail Dystrophy Associated With Cosmetic Nail Products

By Chuck Lin No Comments
INTRODUCTIONDriven by the influence of social media, widespread availability of at-home nail kits, and easily accessible tutorials, the popularity of gel and acrylic nail polishes has surged making these stylish…
Read More
Feb 26
Love0

Persistent Alopecic Patches Following Dutasteride Mesotherapy for Female Androgenetic Alopecia: A Case Series

By Chuck Lin No Comments
INTRODUCTIONAndrogenetic alopecia (AGA) is the most prevalent form of hair loss worldwide, affecting both men and women, with an estimated prevalence of up to 80% in males and approximately 40%…
Read More
Feb 26
Love0

Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema

By Chuck Lin No Comments
INTRODUCTIONChronic hand eczema (CHE) is a common, heterogeneous inflammatory condition affecting the hands and wrists. Etiologic and morphologic patterns, such as irritant, allergic, atopic, hyperkeratotic, vesicular, and mixed presentations, are…
Read More
Feb 26
Love0

Brodalumab’s 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence

By Chuck Lin No Comments
INTRODUCTIONPlaque psoriasis is a chronic immune-mediated disease driven by proinflammatory cytokines, such as interleukin (IL)-17, IL-12, IL-23, and/or tumor necrosis factor-alpha (TNF-alpha).1,2 The joint American Academy of Dermatology and National…
Read More
Feb 26
Love0

Management of Nail Toxicities From Fibroblast Growth Factor Receptor Inhibitors

By Chuck Lin No Comments
INTRODUCTIONFibroblast growth factor receptor inhibitors (FGFRi) are a novel class of targeted therapies used in the treatment of FGFR-mutant malignancies. Aberrant FGFR signaling via gene amplification, overexpression, activating mutations, or…
Read More
Feb 26
Love0

Transitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity

By Chuck Lin No Comments
INTRODUCTIONThe concept of 'anti-aging' has been openly used for many years to describe a wide range of changes, from smoothing fine lines and wrinkles to improving hydration and pigmentation. This…
Read More
Feb 26
Love0

Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata

By Chuck Lin No Comments
INTRODUCTIONAlopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss on the scalp and body, with periods of relapse and remission, or complete hair loss on the scalp…
Read More
Feb 26
Love0

Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer’s Disease and Dementia

By Chuck Lin No Comments
INTRODUCTIONHerpes simplex virus (HSV), responsible for oral and genital herpes, impacts over 3 billion people worldwide.1 HSV-1 typically causes oral herpes, while HSV-2 usually leads to genital herpes, though either…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study May 29, 2026
  • Longer Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study May 28, 2026
  • Clinical Methodology to Evaluate the Efficacy of a Topical Cosmetic Eye Formulation on the Appearance of Dynamic Periorbital Lines May 27, 2026
  • Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ May 26, 2026
  • Benzoyl Peroxide and Malignancy Risk: A Systematic Review and Meta-analysis of Over 4 Million Patients May 22, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference LVD        PDE       

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram